Johnson & Johnson Considering Spin-Off of Hips-and-Knees Business
Johnson & Johnson (JNJ) is leaning toward spinning off its hips-and-knees business, according to CFO Joseph Wolk in comments shared with the Wall Street Journal. The company has been evaluating options for this segment and now appears inclined towards a spin-off as part of broader strategic moves aimed at value creation. The decision reflects J&J's ongoing efforts to streamline operations by divesting non-core or underperforming units, particularly within its medical devices division. This move could potentially unlock shareholder value by allowing the hips-and-knees business to operate independently and attract focused investment.
Tickers: $JNJ